SPM-2551 demonstrated robust and durable pharmacological activity following a single low-dose administration in preclinical Duchenne muscular ...

Because technology is a part of columnist Shalom Lim's daily life with Duchenne muscular dystrophy, he weighs in on the ...

The development comes from the University of California, Berkeley. Success with the new delivery system saw an 18-times-higher correction rate together with a two-fold increase in a strength and ...

In a study published in Scientific Reports, an international, multidisciplinary research team that included Binghamton University researchers identified a set of blood proteins that may explain why ...

A drug from the same family licensed for use in patients with Duchenne muscular dystrophy and blood cancer could transform the treatment of meningioma—the most common form of primary brain tumor in ...